CG
HZNP

Cutler Group’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Cutler Group’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-6,450
Closed -$746K – 4600
2023
Q3 		$746K Buy
6,450
+2,122
+49% +$228K 0.08% 310
2023
Q2 		$445K Buy
4,328
+2,128
+97% +$225K 0.06% 364
2023
Q1 		$240K Sell
2,200
-12,537
-85% -$1.39M 0.02% 608
2022
Q4 		$1.68M Buy
+14,737
New +$1.22M 0.14% 153
2022
Q3 		– Sell
-300
Closed -$21K – 5868
2022
Q2 		$23K Sell
300
-30,069
-99% -$2.85M ﹤0.01% 2578
2022
Q1 		$3.19M Buy
30,369
+21,474
+241% +$2.09M 0.17% 124
2021
Q4 		$958K Sell
8,895
-3,911
-31% -$427K 0.04% 468
2021
Q3 		$1.4M Buy
12,806
+11,511
+889% +$1.19M 0.06% 347
2021
Q2 		$121K Buy
+1,295
New +$119K 0.01% 1712
2021
Q1 		– Sell
-12,133
Closed -$1.02M – 6665
2020
Q4 		$887K Buy
12,133
+3,833
+46% +$285K 0.04% 435
2020
Q3 		$644K Buy
+8,300
New +$571K 0.04% 450
2019
Q4 		– Sell
-3,000
Closed -$81K – 4981
2019
Q3 		$81K Sell
3,000
-1,000
-25% -$25.9K 0.01% 1200
2019
Q2 		$96K Sell
4,000
-500
-11% -$12.7K 0.01% 1122
2019
Q1 		$118K Sell
4,500
-5,500
-55% -$130K 0.01% 922
2018
Q4 		$195K Sell
10,000
-4,500
-31% -$88.2K 0.02% 652
2018
Q3 		$283K Sell
14,500
-1,000
-6% -$19K 0.02% 686
2018
Q2 		$256K Sell
15,500
-5,500
-26% -$83.9K 0.02% 679
2018
Q1 		$298K Sell
21,000
-2,328
-10% -$34.4K 0.03% 622
2017
Q4 		$340K Sell
23,328
-15,722
-40% -$221K 0.01% 702
2017
Q3 		$495K Sell
39,050
-3,381
-8% -$43K 0.02% 665
2017
Q2 		$503K Sell
42,431
-7,943
-16% -$98.8K 0.02% 689
2017
Q1 		$744K Sell
50,374
-96,891
-66% -$1.57M 0.03% 497
2016
Q4 		$2.38M Sell
147,265
-4,819
-3% -$87.4K 0.09% 177
2016
Q3 		$2.76M Buy
152,084
+88,054
+138% +$1.72M 0.12% 124
2016
Q2 		$1.05M Buy
64,030
+15,044
+31% +$243K 0.05% 281
2016
Q1 		$811K Buy
48,986
+15,821
+48% +$277K 0.05% 327
2015
Q4 		$718K Buy
+33,165
New +$646K 0.04% 458

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Cutler Group's HZNP Position: Q4 2023 in Review

Cutler Group sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 6,450 shares — an estimated $746K sold.

Cutler Group first reported a position in HZNP in Q4 2015 and held it in 27 quarters. The position peaked at $3.19M in Q1 2022. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Cutler Group reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Cutler Group sold 6,450 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $746K.
  • Cutler Group first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2015 and held it in 27 quarters.
  • Cutler Group's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $3.19M in Q1 2022.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Cutler Group's 13F filing for Q4 2023, filed 18 Jan 2024.